A landmark study of nearly 30,000 patients found that the use of GLP-1 medications, which include Wegovy and Ozempic, could ...

As GLP-1s quiet the constant hum of hunger, are they a permanent pharmaceutical crutch, or can they create space to let us ...

But this is just the start. GLP-1 drugs (specifically Novo Nordisk’s Ozempic, Rybelsus and Wegovy and Eli Lilly’s Mounjaro ...

Consumers may cycle on and off GLP-1 medications because of financial constraints. These consumers present opportunities for ...

Since starting a GLP-1 medication, McBride has lost 45 pounds. She still meets with her online provider regularly and is considering switching to a maintenance dose. “I’m happy that something ...

then I’ll be really happy with that.” On Tuesday, ChipMonk started accepting preorders for three varieties of cookies that aim to boost naturally occurring levels of the GLP-1 hormone ...

Whether patients add glucagon-like peptide 1 (GLP-1) medications really depends on if they’re having success with weight loss, said Tronieri. Patients wouldn’t want to add them if they were ...

The family of medications called GLP-1 receptor agonists includes drugs like Wegovy, Zepbound, Ozempic, Mounjaro and Victoza. They were originally developed to treat type 2 diabetes, which happens ...

Semaglutide, the GLP-1 agonist drug that powers Wegovy, could cost less than $100,000 per qualify-adjusted life year added once its price falls to $1,522 per year, from an average of about $8,412 ...

Could a diabetes drug slash your cancer risk? New research shows GLP-1 receptor agonists may protect patients with type 2 diabetes from deadly blood cancers—beyond just managing blood sugar.

The GLP-1 industry is currently an oligopoly ruled by two pharmaceutical giants, Novo Nordisk A/S (NYSE: NVO), maker of semaglutide under the Ozempic and Wegovy name brands, and Eli Lilly & Co ...